In 2023, the import of syringes to France was valued at 677.4 million US dollars. The forecast for 2024 suggests an increase to 691.02 million US dollars, marking a year-on-year growth of 2.0%. This trend of moderate growth is expected to continue, with imports reaching 748.84 million US dollars by 2028. The compound annual growth rate (CAGR) over the forecast period (2024-2028) is approximately 2.0%, indicating a stable upward trajectory. The consistent growth can be attributed to rising healthcare needs and innovations in medical technology.
Looking ahead, it will be essential to observe the impact of regulatory changes in medical devices, potential advancements in syringe production technology, and shifts in healthcare policies, which could influence France's import dynamics in the coming years.
